FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014148051> ?p ?o ?g. }

• W2014148051 endingPage "255" @default.
• W2014148051 startingPage "248" @default.
• W2014148051 abstract "Breast cancer is the most common cancer among women. Up to 75% of breast cancers express the estrogen receptor (ER)α and/or the progesterone receptor (PR). Patients with hormone receptor-positive metastatic breast cancer are typically treated with endocrine therapy. Yet, not all patients with metastatic breast cancer respond to endocrine treatments and are considered to have primary (de novo) resistance. Furthermore, all patients who initially respond to endocrine treatment will eventually develop acquired resistance. Several mechanisms have been linked to the development of endocrine resistance, including reduced expression of ERα, altered regulation of the ER pathway, and activation of various growth factor signaling pathways, among them the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway. This pathway is involved in critical processes including cell survival, proliferation, and angiogenesis, and plays a central role in breast cancer development. Recent laboratory and clinical data implicate this pathway as mediating endocrine resistance, and agents directed against critical components of this pathway are either already approved for clinical use in breast cancer patients or are currently being tested in clinical trials. In this review, we describe the interaction between the PI3K/Akt/mTOR pathway and the ER cascade, its role in mediating endocrine resistance, and the clinical implications of this interaction." @default.
• W2014148051 created "2016-06-24" @default.
• W2014148051 creator A5001107199 @default.
• W2014148051 creator A5059311303 @default.
• W2014148051 creator A5062850935 @default.
• W2014148051 creator A5083392542 @default.
• W2014148051 date "2013-01-01" @default.
• W2014148051 modified "2023-10-18" @default.
• W2014148051 title "Endocrine Resistance in Breast Cancer: Focus on the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway" @default.
• W2014148051 cites W1599727238 @default.
• W2014148051 cites W1961026612 @default.
• W2014148051 cites W1974942240 @default.
• W2014148051 cites W1981711832 @default.
• W2014148051 cites W1985453548 @default.
• W2014148051 cites W1989954597 @default.
• W2014148051 cites W1990883066 @default.
• W2014148051 cites W1997006452 @default.
• W2014148051 cites W2007114641 @default.
• W2014148051 cites W2011705265 @default.
• W2014148051 cites W2013956549 @default.
• W2014148051 cites W2022742795 @default.
• W2014148051 cites W2026493214 @default.
• W2014148051 cites W2026842712 @default.
• W2014148051 cites W2028122342 @default.
• W2014148051 cites W2029348880 @default.
• W2014148051 cites W2029882446 @default.
• W2014148051 cites W2037317523 @default.
• W2014148051 cites W2043054566 @default.
• W2014148051 cites W2043753066 @default.
• W2014148051 cites W2046410395 @default.
• W2014148051 cites W2048131754 @default.
• W2014148051 cites W2061551473 @default.
• W2014148051 cites W2071394735 @default.
• W2014148051 cites W2073869705 @default.
• W2014148051 cites W2082887122 @default.
• W2014148051 cites W2090631044 @default.
• W2014148051 cites W2095838797 @default.
• W2014148051 cites W2100506877 @default.
• W2014148051 cites W2102369206 @default.
• W2014148051 cites W2112001957 @default.
• W2014148051 cites W2112444654 @default.
• W2014148051 cites W2113458582 @default.
• W2014148051 cites W2115950635 @default.
• W2014148051 cites W2117357260 @default.
• W2014148051 cites W2121917721 @default.
• W2014148051 cites W2126783165 @default.
• W2014148051 cites W2140022713 @default.
• W2014148051 cites W2141764540 @default.
• W2014148051 cites W2144957807 @default.
• W2014148051 cites W2146778486 @default.
• W2014148051 cites W2151010413 @default.
• W2014148051 cites W2151791302 @default.
• W2014148051 cites W2153061474 @default.
• W2014148051 cites W2155228605 @default.
• W2014148051 cites W2157983986 @default.
• W2014148051 cites W2165948908 @default.
• W2014148051 cites W2167188058 @default.
• W2014148051 cites W2168485476 @default.
• W2014148051 cites W2169689529 @default.
• W2014148051 cites W2243880667 @default.
• W2014148051 cites W2322462095 @default.
• W2014148051 cites W2517054293 @default.
• W2014148051 cites W80291224 @default.
• W2014148051 doi "https://doi.org/10.1159/000354757" @default.
• W2014148051 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3808218" @default.
• W2014148051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24415977" @default.
• W2014148051 hasPublicationYear "2013" @default.
• W2014148051 type Work @default.
• W2014148051 sameAs 2014148051 @default.
• W2014148051 citedByCount "38" @default.
• W2014148051 countsByYear W20141480512013 @default.
• W2014148051 countsByYear W20141480512014 @default.
• W2014148051 countsByYear W20141480512015 @default.
• W2014148051 countsByYear W20141480512016 @default.
• W2014148051 countsByYear W20141480512017 @default.
• W2014148051 countsByYear W20141480512018 @default.
• W2014148051 countsByYear W20141480512019 @default.
• W2014148051 countsByYear W20141480512020 @default.
• W2014148051 countsByYear W20141480512021 @default.
• W2014148051 countsByYear W20141480512022 @default.
• W2014148051 countsByYear W20141480512023 @default.
• W2014148051 crossrefType "journal-article" @default.
• W2014148051 hasAuthorship W2014148051A5001107199 @default.
• W2014148051 hasAuthorship W2014148051A5059311303 @default.
• W2014148051 hasAuthorship W2014148051A5062850935 @default.
• W2014148051 hasAuthorship W2014148051A5083392542 @default.
• W2014148051 hasBestOaLocation W20141480511 @default.
• W2014148051 hasConcept C121608353 @default.
• W2014148051 hasConcept C126322002 @default.
• W2014148051 hasConcept C143998085 @default.
• W2014148051 hasConcept C2775930923 @default.
• W2014148051 hasConcept C46699223 @default.
• W2014148051 hasConcept C502942594 @default.
• W2014148051 hasConcept C530470458 @default.
• W2014148051 hasConcept C62478195 @default.
• W2014148051 hasConcept C71315377 @default.
• W2014148051 hasConcept C71924100 @default.
• W2014148051 hasConcept C75217442 @default.

• next